Page 3 - Les meilleurs doctors en Turquie pour votre Coloscopie - TOP 68 des médecins

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Éducation

Faculté de médecine de l'Université Ondokuz Mayıs (1991)

Faculté de médecine de l'hôpital Farabi de KTÜ (Spécialisation.1998)

Faculté de médecine de l'Université d'Istanbul Çapa (Formation en chirurgie laparoscopique, 2002)

Faculté de médecine de l'Université d'Istanbul Çapa (Formation en chirurgie laparoscopique antireflux, 2006)

Faculté de médecine de l'Université Cerrahpaşa d'Istanbul (Clinique de chirurgie générale, formation en chirurgie laparoscopique avancée, chirurgie bariatrique laparoscopique, formation en chirurgie de l'obésité morbide et du cancer oncologique, 2010i)

Spécialisations

Chirurgie du cancer

Chirurgie du pancréas

Chirurgie des voies biliaires

Chirurgie métabolique bariatrique

Chirurgie oncologique

Chirurgie mammaire

Cancer gastrique

Cancer du côlon

Cancer de la thyroïde

Chirurgie de l'obésité

Chirurgies pour le diabète

Dr. Tülin Kendir Koçak is a board-certified gastroenterologist and internal medicine specialist. She has over 25 years of clinical experience. Dr. Koçak is skilled in advanced endoscopic procedures such as esophagogastroduodenoscopy, colonoscopy, chromoendoscopy, and flexible rectosigmoidoscopy. She has performed many specialized interventions, including esophageal variceal band ligation, achalasia balloon dilatation, polypectomy, foreign body removal, and percutaneous endoscopic gastrostomy (PEG).

Dr. Koçak graduated from Istanbul University Cerrahpasa Faculty of Medicine. She completed her advanced training at leading hospitals in Turkey. She has held important roles in both public and private healthcare institutions. Dr. Koçak’s extensive hands-on experience makes her a respected expert in gastroenterology.

Le Dr Osman Aktas est chirurgien généraliste à l'hôpital Avicenne d'Ataşehir depuis 2005. Né à Kayseri en 1960, il a obtenu son diplôme de médecine à l'Université d'Ankara en 1983. Après avoir obtenu son diplôme, il a effectué son service militaire dans des unités médicales pendant deux ans. Il a effectué sa résidence en chirurgie générale à GATA de 1986 à 1990. Après s'être spécialisé en chirurgie générale, il a occupé des postes clés en tant que chef de service de chirurgie générale et médecin-chef dans plusieurs hôpitaux militaires de premier plan, notamment à Tatvan, Diyarbakır, Ankara et Manisa.

Le Dr Osman se spécialise dans la chirurgie endoscopique depuis 1995. Il a suivi une formation avancée en techniques de chirurgie laparoscopique en Allemagne et a réalisé avec succès une large gamme d'interventions laparoscopiques. Son expertise s'étend à la chirurgie de la vésicule biliaire, aux réparations de la paroi abdominale et de la hernie inguinale, à l'appendicite, au reflux et aux chirurgies de l'estomac, ainsi qu'aux cas complexes tels que les tumeurs gastro-intestinales, les obstructions intestinales et diverses autres maladies intestinales, toutes traitées par des méthodes mini-invasives.

En 2002, le Dr Osman est passé au secteur privé, où il a élargi sa pratique pour inclure des traitements modernes pour les maladies anales comme les hémorroïdes, les fistules et les fissures, en utilisant des techniques avancées telles que la thérapie au laser.

Le Dr Osman est également reconnu pour ses contributions importantes à la chirurgie oncologique. Il possède une vaste expérience dans le traitement chirurgical de divers cancers, notamment du sein et de la thyroïde, où il a mis en œuvre de nouvelles méthodes de traitement qui réduisent le risque de complications. Son expertise chirurgicale couvre les chirurgies oncologiques critiques, telles que la procédure de Whipple pour le cancer du pancréas, les résections du cancer colorectal, le cancer gastrique et d'autres tumeurs malignes complexes. De plus, ses compétences en chirurgie métabolique ont conduit à des résultats durables pour les patients souffrant d'obésité et de diabète, assurant une meilleure qualité de vie grâce à une perte de poids durable et à un risque réduit de diabète.

Grâce à sa vaste expérience et à ses compétences avancées en chirurgie laparoscopique et cancérologique, le Dr Osman reste à la pointe de l’excellence chirurgicale, offrant des soins innovants et complets à tous ses patients.

Éducation

Médecin : Centre de santé n°1 Kilis Merkez, 2006-2008
Médecin assistant : Faculté de médecine de l'Université de Mersin, 2009-2013
Médecin spécialiste : Hôpital d'État de Bingöl Genç, 2013-2014
Assistant mineur : Faculté de médecine de l'Université d'Akdeniz, 2014-2017
Spécialiste mineur : Hôpital régional de formation et de recherche d'Erzurum, 2017-2018
Spécialiste en médecine interne : Hôpital de formation et de recherche de Gaziosmanpaşa, 2018-2020
Spécialiste traitant : Başakşehir Çam et hôpital municipal de Sakura, 2020-2022
Professeur agrégé : Başakşehir Çam et hôpital municipal de Sakura, 2023
Professeur agrégé : Hôpital Medicalpark Gaziosmanpaşa de l'Université Istinye, 2023-2024

Adhésions scientifiques

Société turque de pédiatrie
Société turque de gastroentérologie, d'hépatologie et de nutrition pédiatriques
ESPGHAN - Société européenne de gastroentérologie, d'hépatologie et de nutrition pédiatriques.

Intérêts médicaux

• 
  -Syndrome du côlon irritable (sans repos)
• -Allergies alimentaires associées au système digestif
• -Constipation, incontinence fécale
• -Diarrhée aiguë et chronique, malabsorption
• -Douleurs abdominales chroniques
• -Reflux gastro-œsophagien
• - Maladie cœliaque
• -Colite ulcéreuse, maladie de Crohn
• -Traitement avant et après transplantation hépatique
• - Pancréatite aiguë et chronique

éducation

Faculté de médecine de l'Université d'İnönü (anglais) 1995-2002

Expérience professionnelle

Premier Ministère SHÇ.EK Direction générale Médecine institutionnelle (2003)

Faculté de médecine de l'Université d'Erciyes, spécialisation en chirurgie générale 2011

Formation de base et avancée sur les interventions endoscopiques de l'Université Yüzüncü Yıl 2011

Hôpital d'Istanbul / Fourgon 2011

Hôpital privé de Malatya / Malatya2012

Centre médical Bilgi Keçiören /Ankara 2013

Hôpital privé Koru Sincan Sincan/Ankara 2013

Chef du Centre Médical /Clinique de Bakou Azerbaïdjan/Bakou 2013

Hôpital privé Koru Ankara de l'Université Yüksek İhtisas 2019

Hôpital privé Ankara Koru / Ankara 2019

Intérêts médicaux

obésité laparoscopique
Réparations laparoscopiques de hernies abdominales et inguinales (avec les dernières techniques)

Diastasis recti laparoscopique post-partum (formation d'une saillie dans la partie supérieure moyenne de l'abdomen en raison de la séparation des muscles dans le tissu abdominal) et hernies abdominales au-dessus du nombril et du nombril, réparation du diastasis recti et réparation de la hernie abdominale à partir de la peau par laparoscope scola pour la première fois en Turquie (hernie laparoscopique de l'estomac et chirurgie antireflux).

Chirurgies laparoscopiques de la vésicule biliaire, y compris le nettoyage des voies biliaires par irrigation cholédocale trans-kystique chez les patients présentant des boues biliaires et des calculs de moins de 5 mm dans les voies biliaires, réalisées au cours de la même séance

Chirurgies laparoscopiques de la vésicule biliaire chez la femme enceinte au cours des 2e et 3e trimestres, c'est-à-dire après 12 semaines de grossesse

Appendicectomie laparoscopique pendant la grossesse

Troubles anaux, fissures anales, tous types de chirurgies des hémorroïdes internes et externes, chirurgies des fissures anales et des fistules anales

Chirurgies et cancers de la thyroïde, chirurgies et cancers de la parathyroïde

Maladies du sein et chirurgie du cancer du sein

Chirurgie oncologique ; chirurgies du foie, de la vésicule biliaire et des voies biliaires, chirurgie du cancer de l'estomac, chirurgie du cancer du côlon et résections hépatiques pour les tumeurs hépatiques métastatiques

Éducation

Faculté de médecine de l'Université Cumhuriyet, 2004
Hôpital de formation et de recherche Haydarpaşa d'Istanbul Résidence en médecine interne, 2010
Résidence en oncologie médicale, Faculté de médecine de l'Université technique de Karadeniz, 2015

Expérience

Centre de cancérologie MD Andeson, États-Unis, 2008
Clinique du cancer du sein du Centre de cancérologie Odette de Sunnybrook, Canada, 2017
Centre de cancérologie Moffit, États-Unis 2022
Hôpital de formation et de recherche Haydarpaşa d'Istanbul Médecine interne, 2010
Clinique de médecine interne de l'hôpital d'État d'İdil, 2011
Université technique de Karadeniz, Faculté de médecine, Clinique d'oncologie médicale, 2015
Hôpital de formation et de recherche Göztepe d'Istanbul, clinique d'oncologie médicale, 2018
Hôpital universitaire Yeniyüzyıl de Gaziosmanpaşa, clinique d'oncologie médicale, 2020
Hôpital Ataşehir Medicana, Clinique d'oncologie médicale, 2022

Adhésion scientifique

Association médicale turque (TTB)
Société turque d'oncologie médicale (TTOD)
Société européenne d'oncologie médicale (ESMO)
Société américaine d'oncologie médicale (ASCO)

Intérêts médicaux

• Cancer du sein
• Cancer du poumon
• Cancer du côlon
• Cancer de l'estomac
• Cancer du rectum
• Cancer de l'ovaire
• Cancer du foie
• Cancer de l'œsophage - Cancer de l'œsophage
• Cancer du rein
• Cancer du larynx – Cancer du larynx
• Cancer de la thyroïde
• Cancers de la tête et du cou
• Cancers gynécologiques
• Cancer du pancréas
• Cancer de l'œsophage - Cancer de l'œsophage
• Cancer de l'utérus
• Cancers du cerveau – Tumeurs cérébrales
• Cancer des tissus mous – Sarcomes
• Cancer de la prostate
• Cancer de la vessie
• Cancer des voies biliaires
• Cancer des testicules
• Cancer du col de l'utérus
• Cancers de la bouche, de la langue et des lèvres
• Cancers du système gastro-intestinal
• Tumeurs osseuses
• Cancers de la trachée et des bronches
• Cancers de la peau - Cancers de la peau
• Tumeurs du système squelettique
• Cancer de la vésicule biliaire
• Mésothéliome

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.

Dr. Kayihan Engin is a Radiation Oncologist. He earned his medical degree from Uludağ University Medical College in 1983. He completed his residency in Radiation Oncology at the Center of Oncology & Nuclear Medicine in Istanbul in 1990. From 1990 to 1994, he pursued a post-doctoral fellowship in Thermoradiotherapy at Thomas Jefferson University in the USA.

Dr. Engin has held key academic and leadership roles. He served as Professor, Chairman, and Faculty Accreditation Coordinator at Uludağ University Medical College from 1991 to 2005. He was also Professor and Director at Anadolu Medical Center between 2004 and 2017. Since 2017, he has led the Oncological Sciences departments at Ceylan International and Medicana Bursa Hospitals. Dr. Engin is known for his work in improving cancer treatment and medical education standards in Turkey.

Dr. Binnur Simsek is a gastroenterology specialist. She has experience in liver cirrhosis, portal hypertension, hepatocellular carcinoma, liver transplantation, and viral hepatitis (B, C, Delta). She also treats alcoholic and non-alcoholic fatty liver disease, peptic ulcers, gastrointestinal bleeding, and inflammatory bowel diseases such as ulcerative colitis and Crohn’s colitis.

She completed her medical and gastroenterology training at Istanbul University Faculty of Medicine. Dr. Simsek has worked at Istanbul University, Sanlıurfa Education and Research Hospital, Liv Hospital, and Istinye University. She is a member of the Turkish Association for the Study of the Liver and the Turkish Society of Gastroenterology.

Prof. Dr. Adil Baykan is a leading general and oncological surgeon in Turkey. He has over 28 years of clinical experience. He specializes in colorectal, endoscopic, and laparoscopic surgeries. He also treats thyroid and breast diseases.

Dr. Baykan has published several articles on colon cancer in national and international journals. He completed advanced training at St. Mark’s Hospital in London, the University of Minnesota, and the Mayo Clinic in the USA. He holds important academic and surgical roles at top hospitals in Turkey.

Éducation

• Diplôme : Faculté de Médecine, Université d'Istanbul, 1994
• Spécialisation : médecine interne, hôpital SBU Haseki, 1998
• Spécialisation : Gastro-entérologie, Hôpital SBU Sisli Etfal, 2007

Expérience

• Professeur associé SBÜ Ümraniye EAH, 2012
• Professeur SBÜ Ümraniye EAH, 2017
• Professeur à l'Université de Biruni, 2023

Adhésions scientifiques

• Association turque de gastroentérologie
• Association Turque du Foie
• Association des maladies inflammatoires chroniques de l'intestin
• HEBIPA (Association pour la lutte contre les infections et la prophylaxie des hépatites)

Récompenses

• « Prix national du chercheur » en 2011 à l'UEGW Stockholm pour son étude intitulée « Thérapie séquentielle et triple à base de lévofloxacine comparée à une combinaison standard plus probiotique pour l'éradication d'Helicobacter Pylori ».
• « Coexistence de colite microscopique et de colite active focale chez les patients atteints du syndrome du côlon irritable » 3ème prix dans la catégorie Poster à la 23ème Semaine Nationale de Gastroentérologie 2006.
• « Enquête sur les voies de dommages dans le tissu hépatique dans l'hépatite B chronique : une étude protéomique comparative » dans le 26e numéro de la revue turque J. Gastroenterol en 2015.
• "Investigations des variantes du gène EGF et de son récepteur EGFR dans la colite ulcéreuse", 3ème prix dans la catégorie Présentation orale au XVème Congrès eurasien de gastroentérologie et de chirurgie 2016.
• 1er prix dans la catégorie Présentation Orale au XVIe Congrès National des Hépatites en 2023 avec l'étude intitulée « Evaluation prospective des résultats du suivi à quatre ans des patients atteints d'hépatite C dans le suivi AMATEM ».

Intérêts médicaux

• EUS
• CPRE
• Cholangioscopie
• POÈME
• Ballon gastrique
• Décharge électrostatique
• Coloscopie
• Polypectomie
• Maladies inflammatoires chroniques de l'intestin
• Cirrhose du foie
• Reflux gastro-œsophagien,
• Maladies fonctionnelles
• SCI
• Dyspepsie
• Motilité
• Manométrie

Areas of Interests

• General Gastrointestinal Diseases
• Endoscopic procedures (gastroscopy, colonoscopy, enteroscopy, capsule endoscopy)
• Interventional endoscopy
• ERCP
• Endoscopic ultrasonography (EUS)
• Cholangioscopy
• Diseases of the biliary system and pancreas

Education:
 

• 1990 -1996 Ankara University Faculty of Medicine
• 1997 - 2001 Ankara Numune Training and Research Hospital Internal Medicine Residency
• 2001 - 2003 Turkey High Specialization Training and Research Hospital, Gastroenterology Subspecialization
• 2010 - 2010 State University of New York, USA, Department of Gastroenterology, EUS training program
   

Experience:
 

• June 2024 LIV Hospital Ulus Hospital
• 2018 - 2024 Florence Nightingale Hospitals, Gastroenterology Clinic
• 2013 - 2018 Memorial Ataşehir Hospital, Gastroenterology Clinic
• 2008 - 2013 Gaziantep University Faculty of Medicine, Department of Gastroenterology, Assoc. Prof. Dr.
• 2008 - 2008 Medicalpark Gaziantep Hospital Gastroenterology Clinic
• 2004 - 2008 Gaziantep State Hospital Gastroenterology Clinic, Endoscopy Unit Founding Physician

Publications

• Arhan M, Koklu S, Koksal AS, Yolcu OF, Koruk S, Koruk I, Kayacetin E. Alverine citrate induced acute hepatitis. World J Gastroenterol 2004; 10(15): 2303-4  ISSN: 1007-9327
• Parlak E, Cicek B, Koruk I, Disibeyaz S, Sahin B. Successful prevention of stent migration caused by placement of a second stent. Endoscopy. 2005; 37(4): 404. ISSN: 0013-726X
• Koruk I, Ozturk ZA, Köklü S, Koruk S, Ozdede S. Port-site metastasis after laparoscopic cholecystectomy. Acta Gastroenterol Belg. 2008; 71(2): 283-4      ISSN:0001-5644
• Koruk I, Parlak E, Secilmis S, Akdogan M, Koklu S.  Endoscopic sphincteroplasty with large balloon dilatation for extraction of difficult common bile duct stones. Dig Dis Sci. 2008 Jun;53(6):1737-8. ISSN: 0163-2116
• Ozkaya M, Yuzbasioglu MF, Koruk I, Cakal E, Sahin M, Cakal B. Preoperative detection of insulinomas: two case reports. Cases J. 2008 Nov 29; 1(1): 362  ISSN: 1757-1626
• Yılmaz Ö, Koruk İ, Çayır K, Koruk M, Yılmaz A. Usefullness of serum insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) for colorectal cancer diagnosis. Int J Hematol Oncol 2009; 19(1): 23-27  ISSN: 1306-133X
• Savaş C, Koruk İ, Koruk M, Kadayıfçı A, Sarı İ. Association of prion protein with the stage of liver fibrosis in chronic viral hepatitis. Trakya Univ Tip Fak Derg. 2010; 27(4): 373-7. DOI: 10.5174/tutfd.2009.02284.1 ISSN: 1301-3149
• Buyukberber M, Koruk I, Cıkman O, Koruk M, Kucukoglu ME, Sakman A, Demir O, Sahinoz S. Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases. Ann Hepatol 2010; 9(1): 58-62  ISSN: 1665-2681
• Gulsen MT, Koruk I, Dogan M, Beyazit Y. Diagnostic accuracy of cascade stomach by upper gastrointestinal endoscopy in patients with obscure symptoms: A multi-center prospective trial. Clin Res Hepatol Gastroenterol. 2011; 35: 489-93. DOI: 10.1016/j.clinre.2011.03.004         ISSN: 2210-7401
• Koruk I, Aydın U, Koruk S, Aydınlı M. A newly defined biliary anatomic variation. Turk J Gastroenterol 2011; April 22(2): 232-3  DOI:10.4318/ tjg.2011.0204  ISSN: 1300-4948
• Koruk İ, Özdemir H, Aydınlı M, Tarakçıoğlu M, Koruk M. The relation between serum Cytokeratin 18 and acute pancreatitis: Can it be a serological predictive marker?. Turk J Gastroenterol. 2011. DOI:10.4318/tjg.2011.0256 ISSN: 1300-4948
• Aydinli M, Koruk I, Koruk S, Aydin U, Kadayifci A. Intraoperative cholangioscopy with an ultrathin endoscope for hemobilia. Endoscopy 2011;43 Suppl 2 UCTN:E410. doi: 10.1055/s-0030-1256897. Epub 2012 Jan 24
• Aydinli M, Koruk I, Dag MS, Savas MC, Kadayifci A. Ultrathin endoscopy for gastrointestinal strictures. Digestive Endoscopy 2012 May;24(3):150-3. doi: 10.1111/j.1443-1661.2011.01206.x. Epub 2011 Oct 27                 ISSN: 0915-5635
• Yılmaz Ö, Koruk İ, Onbaş O, Ozgokce M. Portal venous gas resulting from enteritis in a case with portal hypertension: Case report. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2012; 32 (4): 1195-8 ISSN: 1300-0292
• Demiryürek S, Koruk I, Bozdag Z, Ozkara E, Kaplan DS, Oztuzcu S, Cetinkaya A, Alasehirli B, Demiryürek AT. Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. Ultrastruct Pathol. 2013 Aug;37(4):284-9. doi: 10.3109/01913123.2013.797064        ISSN: 0191-3123
• Dag MS, Ozturk ZA, Koruk I, Kısacık B, Gerenli O, Aydınlı M, Kadayıfcı A. Intestinal Behcet's disease with severe pulmonary arterial involvement mimicking ulcerative colitis. Asian Biomedicine. 2013; 7(5): 715-8      ISSN: 1905-7415
• Dağ MS, Aydınlı M, Oztürk ZA, Türkbeyler IH, Koruk I, Savaş MC, Koruk M, Kadayıfçı A. Drug- and herb-induced liver injury: a case series from a single center. Turk J Gastroenterol. 2014 Feb;25(1):41-5. doi: 10.5152/tjg.2014.4486ISSN: 1300-4948
• Kadayifci A, Atar M, Parlar S, Balkan A, Koruk I, Koruk M. Transnasal endoscopy is preferred by transoral endoscopy experienced patients. J Gastrointestin Liver Dis. 2014 Mar;23(1):27-31     ISSN: 1841-8724
• Alasehirli B, Oğuz E, Oksuzler E, Koruk I, Oztuzcu S, Ozkara E, Karakok M, Erbagcı AB, Demiryurek AT. Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus. Tumour Biol. 2014 May;35(5):4907-12. doi: 10.1007/s13277-014-1644-3      ISSN: 1010-4283
• Dag M, Özturk Z, Aydınlı M, Koruk I, Kadayfçı A. Postpartum hepatotoxicity due to herbal medicine Teucrium polium. Ann Saudi Med. 2014 Nov-Dec;34(6):541-3. doi: 10.5144/0256-4947.2014.541        ISSN: 0256-4947
• Tahtacı M, İbiş M, Koruk İ, Parlak E. Endoscopic removal of fractured basket traction wire. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:324-5. doi: 10.5152/tjg.2014.6582            ISSN: 1300-4948
• Dağ MS, Koruk İ, Aydınlı M, Çam H, Öztürk ZA, Kadayıfçı A. An unusual cause of esophageal ulcer; sertraline hydrochloride. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:250-1. doi: 10.5152/tjg.2014.4646  ISSN: 1300-4948
• Balkan A, Yılmaz N, Balkan Y, Koruk İ, Örkmez M, Aydınlı M, Koruk M. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection. Arab Journal of Gastroenterology. 2017; 18: 98–103                   ISSN: 1687-1979
• Koruk İ. How to manage difficult cannulation in ERCP. Gastroenterology and Hepatology: Open Access. 2017, 6(3): 00194. DOI: 10.15406/ghoa.2017.06.00194 ISSN: 2373-6372
• Valori R, Cortas G, de Lange T, Balfaqih OS, de Pater M, Eisendrath P, Falt P, Koruk I, et al.  Performance measures for endoscopy services: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative.  Endoscopy 2018; 50: 1186–1204   ISSN 0013-726X
• Koruk S, Koruk I, Mizrak A. A, Bilgi M, Gul R, Bozgeyik S. Dexmedetomidine or midazolam in combination with propofol for sedation in endoscopic retrograde cholangiopancreatography: a randomized double blind prospective study. Videosurgery Miniinv. 2020; 15(3): 526-32 doi.org/10.5114/wiitm.2020.95066